Sodium Oxybate 11014-0673
Product NDC
11014-0673- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- For Suspension, Extended Release
- Product Type
- Drug For Further Processing
- DEA Schedule
- Schedule CIII
- Marketing Start
- January 29, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Sodium Oxybate | 6 g/1 |
Packaging Options(1)
1 PACKET in 1 DRUM (11014-0673-1) / 1582 FOR SUSPENSION, EXTENDED RELEASE in 1 PACKET